eLymphNotes — Provided by the Lymphedema Awareness Fondation

UltimateHealth
HomeCurrent IssuePast IssuesResourcesForumsAbout UsContact UsSite Map

Subscribe Now

Make a Difference -- Donate to LAF Now

Coming Events
Link to Us

Log In

Subscribe

Contributors

Advertising Info

Product Showcase

Classifieds

Press Room


What is Lymphedema?
an abnormal swelling
of the body...Read On


See All Core Content

Home  >  Past Issues  >  ''Florida Protocol'' Medicare and Lymphedema—How it Came to Be

''Florida Protocol'' Medicare and Lymphedema—How it Came to Be
by John M. Macdonald

In 1971, I had completed my training in Vascular and Thoracic surgery at the University of Pittsburgh and St. Bartholomew's Hospital, London, England. As I began my career as a surgeon in Ft. Lauderdale, Florida, I never imagined the twists and turns that would lead to my present involvement in wound healing and Lymphedema. The specialty of cardiovascular surgery is rich in mental and physical demands and for more than 27 years I was involved as an active surgeon in private practice and as an active member of local and national medical organizations. Two experiences during these years redirected the focus of my career. The forces of change began when, in 1987, I traveled to the nation of Haiti. At that time, Jean-Claude Duvalier, ( Baby Doc), had been removed from power and the government appointed General Henri Namphy to be the head of state. A number of years prior to that time, good friends of the general had come to the United States for elective surgery under my care. As my friendship with the Haitian community evolved, my wife and I were asked to visit this fascinating country one and one-half hours flight time from Miami. Shortly after our second visit, General Namphy was exiled to the Dominican Republic. By this time my fascination with Haiti and my contacts within the Haitian community had grown considerably. This allowed us to return to Haiti many times over the next 13 years with opportunities to visit medical clinics, interview physicians and nurses while enjoying the friendship of Haitian and American governmental personnel. Haiti was unlike any nation in the Western Hemisphere. In 1997, there were 7.2 million people in Haiti with fewer than 400 hospital beds in the entire country.

One evening at a cocktail party in Port-au-Prince, William Swing, the American Ambassador to Haiti at the time, said to me, "John, what is it that you are doing with this new clinic you are developing in Florida"? I began to explain my interest in wound healing and the relationship to Lymphedema when He asked, "What is Lymphedema?" This was followed by, "Is that the same thing as elephantiasis?" And, "Did you know that there is an elephantiasis colony in the town of Leogane?" "In fact, the Center for Disease Control has been working there for a year." The town of Leogane is a once prosperous town 30 km. south of Port-au-Prince. The area is very tropical with abundant moisture, greenery and verdant pastures, very different than the deforested majority of the country. The blessing of the fertile soil is balanced, Haitian style, by the abundance of mosquitoes. In a population of 120,000, 5% of the people are afflicted with filiariasis---leg Lymphedema being the most common limb involvement. 30% of the male population is afflicted with genital filiariasis. It was evident to me that I had to visit Leogane and see what kind of pneumatic pumps the CDC was using to treat filiariasis.

The second event redirecting my medical career was a phone call made to Marshall Webster, M.D. in 1992. Dr. Webster is Professor of Vascular Surgery and a former fellow resident in thoracic surgery at the University of Pittsburgh. Dr. Webster had published an article on wound healing and I noted that The University of Pittsburgh had a clinic, founded in 1988, called "The Wound Healing and Limb Preservation Clinic." My interest in this field was further stimulated and eventually, in 1993, I founded the North Ridge Hospital Wound and Limb Preservation Center in Ft. Lauderdale, Florida. I began to learn more about wound healing but also, and probably more important at the time, wanted to increase my vascular surgical caseload. Not knowing the difference between algeron and alginate, alginate being an everyday wound care dressing, I began to attend as many wound care conferences as possible and slowly developed knowledge and an appreciation for the fascinating specialty of wound care. Also, I had become aware that the majority of the physicians in the United States had little appreciation for the value of this new/old discipline. There was an obvious need for physicians to become involved. Knowledgeable nurses were frustrated with the inability to gain acceptance for this new discipline. Sadly, this scenario continues in our hospitals as this article is being written.

In January of 1997, we returned from our second Leogane visit. Daily, we were impressed by the clinical improvement achieved in a primitive setting. One physical therapist with only basic Vodder training supervised the program. The results were impressive. The staff of seven to ten dedicated trainees tended to hundreds of Lymphedema patients. Outcomes were recorded and evaluated by the CDC under the direction of David Addis, M.D., a physician in the Public Health Dept., Atlanta, Georgia. Returning from Haiti, I was convinced that Comprehensive Decongestive Physiotherapy was the standard of care for Lymphedema.

That month, Holy Cross Hospital encouraged me to give a presentation at their weekly public forum called "Dinner with the Doctor". A newspaper advertisement appeared in the Sunday edition of the local newspaper - "Lymphedema, Diagnoses and Treatment ." The following Wednesday, I was startled to discover an audience of 350 awaiting my lecture. I asked, "How many of you are here for the Sweet and Low and how many of you are here because of Lymphedema?" The majority raised their hands for the latter. During my presentation I apologized because I realized that main stream American medicine had ignored their plight. At that time, there was one clinic in Ft. Lauderdale offering CDP. However, to my recollection, this was the only clinic with a physician director in the state of Florida. Programs offered consisted of the European standard of two sessions a day for four weeks. Very few insurance companies would reimburse for this protocol. The average cost of $10,000-$15,000 was prohibitive for the majority. Clearly, the suffering Lymphedema population of Florida deserved better.

For a number of years prior to these events, Medicare Florida had been repeatedly petitioned for acceptance and reimbursement for CDP as the the standard of care for Lymphedema. Dr. Robert Lerner, a pioneer in the introduction of CDP in the United States, led the drive for medicare reimbursement in Florida. He was assisted by numerous in state and out of state Lymphedema activists and lobbying groups. The core of their petition requested the standard program of four weeks of therapy with twice-daily therapy sessions. In keeping with the European system, patient education and outcome documentation was not stressed. Medicare's response to this drawn out, intense lobbying effort was detailed in an advisory dated October 20, 1996, written by Sidney Sewell, M.D. Dr. Sewell was, and remains, the Medical Director of Medicare Florida. Dr. Sewell stated then that Comprehensive Decongestive Physiotherapy was considered "experimental." As far as Florida Medicare was concerned, the case was closed.

Because of the Haitian experience, I was convinced that professionally presented medical logic could be used to reverse this decision. It was very apparent that unless we could obtain some form of third party reimbursement, we were never going to be able to support my vision of an integrated wound care-Lymphedema center. Nancy Sims, a registered nurse, certified as a Lymphedema therapist, had been working as a freelance caregiver in Lymphedema in Florida since the late 1980`s. We met at an NLN conference in San Francisco in September 1996. She shared her extensive Lymphedema experience with me and it was obvious that her dedication and professionalism were exactly what was needed to conduct a new Lymphedema assault on Medicare Florida. Attempting to gather documenting medical data, we contacted the original medicare petitioners. To our dismay, we were totally rebuffed. Sadly, even requests for reference articles were refused. I was told personally by an out of state lobbyist that "This was a business matter and that she had not received permission to assist our efforts." We discovered that there were a number of main stream Lymphedema leaders in the United States with little sense of professional collegiality and, in fact, appeared to be severely compromised by economic and territorial concern.

In retrospect, this experience strengthened our resolve. Nancy and I, together with a local chiropractor gathered volumes of current world literature. We were extremely fortunate to receive advice from Judith Purtell, an occupational therapist practicing in Milwaukee, Wisconsin. Her insight into the practical aspects of therapy proved invaluable. While the input from each of these sources was important, the Haitian experience ultimately provided the catalyst that captured the imagination of the authorities. If we could achieve these results in Haiti, under primitive conditions, why not Florida?

Once our review of the literature was completed, packets of information were sent to five highly regarded physicians, practicing in Florida. This group included the specialties of Oncology, Physical Medicine, Cardiovascular Surgery and Vascular Surgery. I spoke at length with each of these physicians. We reviewed the statistics from Leogane, Haiti as detailed by Dr. Addis and the Center for Disease Control. We abstracted what was available in the English language medical literature. When each of these physicians was convinced that CDP offered a viable medical option, they agreed to write a supportive letter to Dr. Sewell. In response to this independent physician input, Dr. Sewell agreed to review his previous decision. Our clinic then wrote a new proposal that would allow the essential aspects of the European system to be defined using established CPT codes. We felt it very important that physical therapy time limits or monetary caps not define the program. It was essential that the new protocol be medically correct, attentive to American socioeconomic realities, easily documentable and fraud proof. It is important to note that documentation of functional physical and occupational outcomes were stressed by the Medicare evaluation office. Medicare then evaluated our recommendations and those of other interested parties. To the enormous credit of Dr. Sewell and his staff, the "Florida Lymphedema Protocol" became law one year to the day after the original denial. October 20, 1997, was a day for celebration.

In essence, the "Florida Protocol" has five basic directives. #1 Diagnoses of Lymphedema must be made by a physician. #2 The physician must write an order for CDP. #3 The patient is evaluated by a physical therapist prior to therapy, at midpoint and at the conclusion of therapy for functional impairment. #4 Patient self-education is stressed and, in fact, if a patient is unable to continue self-therapy either by themselves or with the cooperation of a caregiver, the patient is ineligible for the program. #5 The therapy is limited to ten MLD sessions. The determination to limit the basic protocol to ten MLD encounters was made by the medicare office. With emphasis on patient education and functional outcomes, we believed that these conditions were realistic. In response to medicare approval we also felt an obligation to document the results of this new protocol. It is emphasized that the standard European protocol consists of four weeks duration with twice a day MLD encounters. Patient self-care education is not stressed in the European system.

We knew immediately that this ruling would open Lymphedema therapy, at a reasonable cost, to thousands of patients in our state. We also recognized that while the four-week European program is the gold standard, a significant number of patients would benefit from the ten-treatment program. The original directive stated that it was understood that some patients would require extended treatment sessions and that these patients could be reviewed for approval on an individual case by case request. Numerous articles concerning the Medicare turn around were written in the ensuing months. One article in the Miami Herald quoted a prominent national Lymphedema authority who said, "Were this ten session program accepted nationwide, it would be tragedy for the Lymphedema patients." It was implied that we had distorted accepted therapy. We countered that a half glass was better than an empty glass and began treating patients.

In June of 2000, at the Symposium for Advanced Wound Care in Dallas, Texas, we presented the statistical results on 232 patients treated since opening in 1997. From this group we recorded the volume reduction and percentage edema reduction inpatients receiving exactly ten treatments. We compared these results with previously published German, Australian and American reports using the four week program. Our results were essentially the same as the Australian reports and comparable to the German and American four week findings. We concluded that the "Florida Protocol" compared favorably to the traditional methods of therapy in stage I and II types of Lymphedema.

The journey to arrive at our present level of care for Lymphedema patients in Florida has been both frustrating and exhilarating. Obviously, we are just beginning to fulfill our obligations to Lymphedema patients here and throughout the world. We are adjusting and refining our approach to the Lymphedema patient and to the relationship of wound healing to the variables of Lymphedema. I am excited that with each visit to various cities, hospitals and clinics, I can see a growth of awareness. The dedicated efforts of the original visionaries both professional and lay public are beginning to take seed. The accomplishments and growth of the NLN have been and continue to make significant contributions. Patients previously ignored are receiving proper attention. There is strong evidence that the main stream American medical community is becoming involved and that in the near future it will be the exception rather than the rule to have large areas of North America without accepted Lymphedema support. I speak for each member of our center and for the many dedicated friends who have assisted and continue to assist in this effort. "We are proud to have made a difference."

Florida medicare mandates the use of specific CPT and ICD-9 codes, and requires that certain conditions have been met:

Conditions:
1. There is a physician documented diagnosis of lymphedema: and the physician specifically orders CDP 2. The patient is symptomatic for lymphedema, with limitation of function related to self care, mobility and/or safety. 3. The patient or patient caregiver has the ability to understand and comply with home care continuation of treatment regimen. 4. The services are being performed by a health care professional who has received specialized training in this form of treatment.

ICD-9 diagnosis codes: 457.0 - Post-mastectomy Lymphedema Syndrome 457.1 - Other lymphedema 757.0 - Hereditary edema of the legs (congenital lymphedema)

CPT Codes:

97001 - Physical therapy evaluation

97002 - Physical therapy re-evaluation

97003 - Occupational therapy evaluation

97004 - Occupational therapy re-evaluation

97110 - Therapeutic procedure, one or more areas, each 15 minutes: therapeutic exercises to develop strength and endurance, range of motion and flexibility

97140 - Manual therapy techniques (e.g. mobilization/manipulation, manual lymphatic drainage, manual traction), one or more regions, each 15 minutes

97535 - Self-care/home management training (e.g., activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of adaptive equipment) direct one on one contact by provider, each 15 minutes.



About the Author:
John M. Macdonald
John M. Macdonald, M.D., F.A.C.S.M
B.S., University of Notre Dame
M.D., University of Pennsylvania School of Medicine
Internship--Jackson Memorial Hospital--Univ. of Miami
Residency General and Thoracic Surgery--University of Pittsburgh
Fellowship, Thoracic Surgery--St. Bartholomew Hospital, London England
Board Certified--General Surgery
Board Certified--Thoracic Surgery
Private Practice--Thoracic/Vascular Surgery --Ft Lauderdale, Fla. 1971-1998
Medical Director, North Broward Hospital District, Wound Healing & Lymphedema Center.


Sponsors

GAT Communications

The Jacksonville Lymphedema Clinic

The Rita Foundation



Advertising Opportunities

  Links to external websites were active at the time of posting.


Home  |  Current Issue  |  Events  |  Terms & Conditions  |  Privacy Policies  |  Donate  |  Link to Us

© 2010 eLymphNotes, The First Online Magazine on Lymphedema
Published by The Lymphedema Awareness Foundation (LAF), The Community Network
172 Lakeside Circle, Sanford, FL 32773
laf@elymphnotes.org


Designed, Developed, Deployed by GAT Communications